FDA Finds Multiple Quality Violations At Synthes Plant
The U.S. Food and Drug Administration said Tuesday it discovered several violations at a Synthes Inc. manufacturing facility in Pennsylvania, and sent a warning letter saying applications for devices related to...To view the full article, register now.
Already a subscriber? Click here to view full article